The Asia-Pacific region emerges as a pivotal player in the landscape of clinical trials. They offer unique advantages for conducting impactful research due to diverse populations, varied healthcare infrastructures, and a rich pool of treatment-naive patients. Over the past decade, there has been a notable shift in the global Phase I clinical trials scenario, with […]